Bill Sugden - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Molecular Biology, Cell Biology, Microbiology Biology
Website:
https://mcardle.wisc.edu/faculty/bill-sugden/

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rosemarie Q, Sugden B. Five families of diverse DNA viruses comprehensively restructure the nucleus. Plos Biology. 21: e3002347. PMID 37930945 DOI: 10.1371/journal.pbio.3002347  0.375
2023 Rosemarie Q, Kirschstein E, Sugden B. How Epstein-Barr Virus Induces the Reorganization of Cellular Chromatin. Mbio. e0268622. PMID 36625581 DOI: 10.1128/mbio.02686-22  0.377
2021 Westhoff Smith D, Chakravorty A, Hayes M, Hammerschmidt W, Sugden B. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells. Mbio. e0224321. PMID 34781735 DOI: 10.1128/mBio.02243-21  0.804
2021 Sugden AU, Hayes M, Sugden B. How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell. Viruses. 13. PMID 34452344 DOI: 10.3390/v13081478  0.41
2021 Yang YC, Sugden B. Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product. Frontiers in Microbiology. 12: 643327. PMID 33664726 DOI: 10.3389/fmicb.2021.643327  0.448
2020 Hutcheson RL, Chakravorty A, Sugden B. Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus. Frontiers in Cellular and Infection Microbiology. 10: 606412. PMID 33505922 DOI: 10.3389/fcimb.2020.606412  0.373
2019 Nagaraju T, Sugden AU, Sugden B. Four-dimensional analyses show that replication compartments are clonal factories in which Epstein-Barr viral DNA amplification is coordinated. Proceedings of the National Academy of Sciences of the United States of America. PMID 31744871 DOI: 10.1073/Pnas.1913992116  0.464
2019 Faure A, Hayes M, Sugden B. How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 116: 16519-16528. PMID 31363046 DOI: 10.1073/pnas.1905025116  0.356
2019 Chakravorty A, Sugden B, Johannsen EC. An epigenetic journey: Epstein-Barr virus transcribes chromatinized and subsequently unchromatinized templates during its lytic cycle. Journal of Virology. PMID 30700606 DOI: 10.1128/JVI.02247-18  0.339
2018 Chakravorty A, Sugden B. Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes. Plos Biology. 16: e3000062. PMID 30481166 DOI: 10.1371/journal.pbio.3000062  0.31
2018 Chiu YF, Sugden B. Plasmid-Partitioning by Human Tumor Viruses. Journal of Virology. PMID 29467315 DOI: 10.1128/JVI.02170-17  0.321
2017 Chiu YF, Sugden AU, Fox K, Hayes M, Sugden B. Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally. The Journal of Cell Biology. PMID 28696226 DOI: 10.1083/jcb.201702013  0.316
2017 Yang YC, Liem A, Lambert PF, Sugden B. Dissecting the regulation of EBV's BART miRNAs in carcinomas. Virology. 505: 148-154. PMID 28259048 DOI: 10.1016/J.Virol.2017.02.013  0.312
2016 Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 27698133 DOI: 10.1073/pnas.1605884113  0.355
2016 Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Hammerschmidt W. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. The Journal of Experimental Medicine. PMID 27621419 DOI: 10.1084/jem.20160248  0.394
2016 Chiu YF, Sugden B. Epstein-Barr Virus: The Path from Latent to Productive Infection. Annual Review of Virology. PMID 27578440 DOI: 10.1146/annurev-virology-110615-042358  0.321
2016 Lee D, Norby K, Hayes M, Chiu YF, Sugden B, Lambert PF. Using Organotypic Epithelial Tissue Culture to Study the Human Papillomavirus Life Cycle. Current Protocols in Microbiology. 41: 14B.8.1-14B.8.19. PMID 27153383 DOI: 10.1002/Cpmc.4  0.757
2015 Chakravorty A, Sugden B. The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells. Virology. 484: 251-258. PMID 26122471 DOI: 10.1016/j.virol.2015.05.018  0.444
2014 Shrestha P, Sugden B. Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids. Journal of Virology. 88: 8490-503. PMID 24829342 DOI: 10.1128/JVI.00742-14  0.312
2014 Kuzembayeva M, Hayes M, Sugden B. Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Current Opinion in Virology. 7: 61-5. PMID 24814666 DOI: 10.1016/J.Coviro.2014.04.003  0.802
2014 Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene. 33: 1258-64. PMID 23503461 DOI: 10.1038/Onc.2013.71  0.831
2014 Chakravorty A, Sugden B. 790: Netropsin inhibits the growth of Burkitt's lymphoma cells by forcing the loss of Epstein-Barr virus (EBV) genomes from those cells European Journal of Cancer. 50: S190. DOI: 10.1016/S0959-8049(14)50695-8  0.356
2013 Chiu YF, Sugden AU, Sugden B. Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition. Cell Host & Microbe. 14: 607-18. PMID 24331459 DOI: 10.1016/j.chom.2013.11.009  0.353
2013 Westhoff Smith D, Sugden B. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Viruses. 5: 226-40. PMID 23325328 DOI: 10.3390/v5010226  0.829
2013 Hammerschmidt W, Sugden B. Replication of Epstein-Barr viral DNA. Cold Spring Harbor Perspectives in Biology. 5: a013029. PMID 23284049 DOI: 10.1101/cshperspect.a013029  0.461
2012 Pratt ZL, Sugden B. How human tumor viruses make use of autophagy. Cells. 1: 617-30. PMID 24710493 DOI: 10.3390/Cells1030617  0.801
2012 Norby K, Chiu YF, Sugden B. Monitoring plasmid replication in live mammalian cells over multiple generations by fluorescence microscopy. Journal of Visualized Experiments : Jove. e4305. PMID 23271393 DOI: 10.3791/4305  0.801
2012 Kuzembayeva M, Chiu YF, Sugden B. Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs. Plos One. 7: e47409. PMID 23091622 DOI: 10.1371/Journal.Pone.0047409  0.791
2012 Chiu YF, Sugden B, Chang PJ, Chen LW, Lin YJ, Lan YC, Lai CH, Liou JY, Liu ST, Hung CH. Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturation. Journal of Virology. 86: 9647-55. PMID 22740416 DOI: 10.1128/JVI.01126-12  0.311
2012 Pratt ZL, Zhang J, Sugden B. The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells. Journal of Virology. 86: 4380-93. PMID 22318153 DOI: 10.1128/Jvi.06966-11  0.803
2011 Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp DG, Purvine SO, Gritsenko MA, Li Z, Smith RD, Sugden B, Moore PS, Chang Y. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. Bmc Genomics. 12: 625. PMID 22185355 DOI: 10.1186/1471-2164-12-625  0.803
2011 Vereide DT, Sugden B. Lymphomas differ in their dependence on Epstein-Barr virus. Blood. 117: 1977-85. PMID 21088132 DOI: 10.1182/Blood-2010-05-285791  0.839
2010 Vereide D, Sugden B. Insights into the evolution of lymphomas induced by Epstein-Barr virus. Advances in Cancer Research. 108: 1-19. PMID 21034964 DOI: 10.1016/B978-0-12-380888-2.00001-7  0.828
2009 Vereide D, Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Seminars in Cancer Biology. 19: 389-93. PMID 19628040 DOI: 10.1016/J.Semcancer.2009.07.006  0.835
2009 Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology. 386: 387-97. PMID 19217135 DOI: 10.1016/J.Virol.2009.01.006  0.758
2009 Dresang LR, Vereide DT, Sugden B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. Journal of Virology. 83: 2930-40. PMID 19129441 DOI: 10.1128/Jvi.01974-08  0.769
2009 Lee DY, Lee J, Sugden B. The unfolded protein response and autophagy: herpesviruses rule! Journal of Virology. 83: 1168-72. PMID 18787009 DOI: 10.1128/Jvi.01358-08  0.584
2008 Mack AA, Sugden B. EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Cancer Research. 68: 6963-8. PMID 18757410 DOI: 10.1158/0008-5472.Can-08-0627  0.821
2008 Wang CY, Sugden B. Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 9639-44. PMID 18621728 DOI: 10.1073/Pnas.0801378105  0.596
2008 Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proceedings of the National Academy of Sciences of the United States of America. 105: 5874-8. PMID 18390668 DOI: 10.1073/Pnas.0801130105  0.313
2008 Lindner SE, Zeller K, Schepers A, Sugden B. The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. Journal of Virology. 82: 5693-702. PMID 18385243 DOI: 10.1128/Jvi.00332-08  0.697
2008 Lee DY, Sugden B. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis. Blood. 111: 2280-9. PMID 18042799 DOI: 10.1182/Blood-2007-07-100032  0.563
2008 Lee DY, Sugden B. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy Oncogene. 27: 2833-2842. PMID 18037963 DOI: 10.1038/Sj.Onc.1210946  0.481
2007 Nanbo A, Sugden A, Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. The Embo Journal. 26: 4252-62. PMID 17853891 DOI: 10.1038/Sj.Emboj.7601853  0.481
2007 Lee J, Sugden B. A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1. Journal of Virology. 81: 9121-30. PMID 17581993 DOI: 10.1128/Jvi.00136-07  0.604
2007 Lindner SE, Sugden B. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid. 58: 1-12. PMID 17350094 DOI: 10.1016/J.Plasmid.2007.01.003  0.745
2006 Altmann M, Pich D, Ruiss R, Wang J, Sugden B, Hammerschmidt W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proceedings of the National Academy of Sciences of the United States of America. 103: 14188-93. PMID 16966603 DOI: 10.1073/Pnas.0605985103  0.726
2006 Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Research. 66: 7999-8006. PMID 16912175 DOI: 10.1158/0008-5472.Can-05-4399  0.396
2006 Sugden B. Virology: micro mystery solution. Nature. 442: 33-4. PMID 16823440 DOI: 10.1038/442033A  0.485
2006 Wang J, Lindner SE, Leight ER, Sugden B. Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. Molecular and Cellular Biology. 26: 1124-34. PMID 16428463 DOI: 10.1128/Mcb.26.3.1124-1134.2006  0.782
2006 Hammerschmidt W, Sugden B. 34 Epstein-Barr Virus Cold Spring Harbor Monograph Archive. 47: 687-705. DOI: 10.1101/087969766.47.687  0.552
2005 Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 809-14. PMID 15824148 DOI: 10.1158/1055-9965.Epi-04-0763  0.384
2005 Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseño C, Gires O, Kieser A, Eick D, Sugden B, Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene. 24: 1711-7. PMID 15674340 DOI: 10.1038/Sj.Onc.1208367  0.494
2005 Wang J, Sugden B. Origins of bidirectional replication of Epstein-Barr virus: models for understanding mammalian origins of DNA synthesis. Journal of Cellular Biochemistry. 94: 247-56. PMID 15546145 DOI: 10.1002/Jcb.20324  0.739
2004 Hammerschmidt W, Sugden B. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends in Molecular Medicine. 10: 331-6. PMID 15242681 DOI: 10.1016/J.Molmed.2004.05.006  0.484
2004 Lam N, Sandberg ML, Sugden B. High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. Journal of Virology. 78: 1657-64. PMID 14747531 DOI: 10.1128/Jvi.78.4.1657-1664.2004  0.636
2004 Wang CY, Sugden B. New viruses shake old paradigms. The Journal of Clinical Investigation. 113: 21-3. PMID 14702103 DOI: 10.1172/Jci20662  0.654
2003 Kennedy G, Komano J, Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 100: 14269-74. PMID 14603034 DOI: 10.1073/Pnas.2336099100  0.663
2003 Kennedy G, Sugden B. EBNA-1, a bifunctional transcriptional activator. Molecular and Cellular Biology. 23: 6901-8. PMID 12972608 DOI: 10.1128/Mcb.23.19.6901-6908.2003  0.562
2003 Lam N, Sugden B. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. The Embo Journal. 22: 3027-38. PMID 12805217 DOI: 10.1093/Emboj/Cdg284  0.539
2003 Lam N, Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cellular Signalling. 15: 9-16. PMID 12401515 DOI: 10.1016/S0898-6568(02)00083-9  0.544
2003 Kennedy G, Sugden B. Virus-based vectors for gene expression in mammalian cells: Epstein-Barr virus New Comprehensive Biochemistry. 38: 55-70. DOI: 10.1016/S0167-7306(03)38004-4  0.687
2002 Kaykas A, Worringer K, Sugden B. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. Journal of Virology. 76: 11551-60. PMID 12388716 DOI: 10.1128/Jvi.76.22.11551-11560.2002  0.704
2002 Sugden B. In the beginning: a viral origin exploits the cell. Trends in Biochemical Sciences. 27: 1-3. PMID 11796211 DOI: 10.1016/S0968-0004(01)02032-1  0.525
2001 Sugden B, Takada K. Epstein-Barr virus and human cancer: Hokkaido University, July 4-6, 2001 Japanese Journal of Cancer Research. 92: 1352-1354. PMID 12026875 DOI: 10.1111/J.1349-7006.2001.Tb02160.X  0.366
2001 Leight ER, Sugden B, Light ER. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. Journal of Virology. 75: 10709-20. PMID 11602712 DOI: 10.1128/Jvi.75.22.10709-10720.2001  0.819
2001 Sugden B, Leight ER. EBV's plasmid replicon: an enigma in cis and trans. Current Topics in Microbiology and Immunology. 258: 3-11. PMID 11443865 DOI: 10.1007/978-3-642-56515-1_1  0.813
2001 Leight ER, Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Molecular and Cellular Biology. 21: 4149-61. PMID 11390644 DOI: 10.1128/Mcb.21.13.4149-4161.2001  0.82
2001 Kaykas A, Worringer K, Sugden B. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. The Embo Journal. 20: 2641-54. PMID 11387199 DOI: 10.1093/Emboj/20.11.2641  0.688
2000 Sandberg ML, Kaykas A, Sugden B. Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. Journal of Virology. 74: 9755-61. PMID 11000250 DOI: 10.1128/Jvi.74.20.9755-9761.2000  0.746
2000 Kaykas A, Sugden B. The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation. Oncogene. 19: 1400-10. PMID 10723131 DOI: 10.1038/Sj.Onc.1203365  0.725
2000 Leight ER, Sugden B. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Reviews in Medical Virology. 10: 83-100. PMID 10713596 DOI: 10.1002/(Sici)1099-1654(200003/04)10:2<83::Aid-Rmv262>3.0.Co;2-T  0.833
1999 Bloss T, Kaykas A, Sugden B. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity. The Journal of General Virology. 80: 3227-32. PMID 10567655 DOI: 10.1099/0022-1317-80-12-3227  0.716
1999 Mackey D, Sugden B. Applications of oriP plasmids and their mode of replication Methods in Enzymology. 306: 308-328. PMID 10432462 DOI: 10.1016/S0076-6879(99)06020-6  0.516
1999 Mackey D, Sugden B. The linking regions of EBNA1 are essential for its support of replication and transcription Molecular and Cellular Biology. 19: 3349-3359. PMID 10207059 DOI: 10.1128/Mcb.19.5.3349  0.552
1998 Aiyar A, Sugden B. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of Simian virus 40 replicate their cognate origins Journal of Biological Chemistry. 273: 33073-33081. PMID 9830062 DOI: 10.1074/jbc.273.49.33073  0.354
1998 Aiyar A, Tyree C, Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element Embo Journal. 17: 6394-6403. PMID 9799247 DOI: 10.1093/emboj/17.21.6394  0.415
1998 Kirchmaier AL, Sugden B. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus Journal of Virology. 72: 4657-4666. PMID 9573229 DOI: 10.1128/Jvi.72.6.4657-4666.1998  0.398
1997 Mackey D, Sugden B. Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1 Journal of Biological Chemistry. 272: 29573-29879. PMID 9368061 DOI: 10.1074/Jbc.272.47.29873  0.447
1997 Kirchmaier AL, Sugden B. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus Journal of Virology. 71: 1766-1775. PMID 9032305 DOI: 10.1128/Jvi.71.3.1766-1775.1997  0.383
1995 Kempkes B, Pich D, Zeidler R, Sugden B, Hammerschmidt W. Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA Journal of Virology. 69: 231-238. PMID 7983714  0.439
1995 Gahn TA, Sugden B. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene Journal of Virology. 69: 2633-2636. PMID 7884916  0.441
1995 Kirchmaier AL, Sugden B. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus Journal of Virology. 69: 1280-1283. PMID 7815506 DOI: 10.1128/Jvi.69.2.1280-1283.1995  0.32
1995 Mackey D, Middleton T, Sugden B. Multiple regions within EBNA1 can link DNAs Journal of Virology. 69: 6199-6208. PMID 7666521 DOI: 10.1128/Jvi.69.10.6199-6208.1995  0.46
1995 Kirchmaier AL, Bloss TA, Mackey D, Sugden B. [5] Epstein-barr viral plasmid vectors and their amplifiable derivatives Methods in Molecular Genetics. 7: 65-86. DOI: 10.1016/S1067-2389(06)80037-3  0.532
1994 Middleton T, Sugden B. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1 Journal of Virology. 68: 4067-4071. PMID 8189545  0.375
1994 Bloss TA, Sugden B. Optimal lengths for DNAs encapsidated by Epstein-Barr virus Journal of Virology. 68: 8217-8222. PMID 7966614  0.344
1994 Sugden B. Latent infection of B lymphocytes by Epstein-Barr virus Seminars in Virology. 5: 197-205. DOI: 10.1006/Smvy.1994.1021  0.414
1993 Gahn TA, Sugden B. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation Journal of Virology. 67: 6379-6386. PMID 8411339  0.377
1993 Martin JM, Veis D, Korsmeyer SJ, Sugden B. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2 Journal of Virology. 67: 5269-5278. PMID 8394449  0.362
1993 Sugden B. How some retro-viruses got their oncogenes Trends in Biochemical Sciences. 18: 233-235. PMID 8212128 DOI: 10.1016/0968-0004(93)90168-M  0.385
1992 Middleton T, Sugden B. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication Journal of Virology. 66: 489-495. PMID 1309258  0.368
1991 Martin J, Sugden B. The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 2: 653-600. PMID 1667088  0.335
1991 Su W, Middleton T, Sugden B, Echols H. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1 Proceedings of the National Academy of Sciences of the United States of America. 88: 10870-10874. PMID 1660153 DOI: 10.1073/Pnas.88.23.10870  0.311
1991 Middleton T, Gahn TA, Martin JM, Sugden B. Immortalizing genes of Epstein-Barr virus Advances in Virus Research. 40: 19-55. PMID 1659776  0.462
1990 Hammerschmidt W, Sugden B. DNA replication of herpesviruses during the lytic phase of their life-cycles Molecular Biology and Medicine. 7: 45-57. PMID 2157936  0.311
1990 Sternas L, Middleton T, Sugden B. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells Journal of Virology. 64: 2407-2410. PMID 2157896  0.416
1989 Baichwal VR, Hammerschmidt W, Sugden B. Characterization of the BNLF-1 oncogene of Epstein-Barr virus Current Topics in Microbiology and Immunology. 144: 233-239. PMID 2551585  0.324
1989 Hammerschmidt W, Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes Nature. 340: 393-397. PMID 2547164  0.428
1989 Sugden B, Warren N. A promotor of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection Journal of Virology. 63: 2644-2649. PMID 2542577  0.419
1989 Hammerschmidt W, Sugden B, Baichwal VR. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels Journal of Virology. 63: 2469-2475. PMID 2542565  0.335
1988 Hammerschmidt W, Sugden B. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus Cell. 55: 427-433. PMID 2846181 DOI: 10.1016/0092-8674(88)90028-1  0.41
1988 Sugden B, Warren N. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis Molecular Biology &Amp; Medicine. 5: 85-94. PMID 2840551  0.411
1988 Baichwal VR, Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus Oncogene. 2: 461-467. PMID 2836780  0.342
1987 Baichwal VR, Sugden B. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus Journal of Virology. 61: 866-875. PMID 3027413  0.358
1987 Mecsas J, Sugden B. Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture Annual Review of Cell Biology. 3: 87-108. PMID 2825737 DOI: 10.1146/Annurev.Cb.03.110187.000511  0.413
1986 Reisman D, Sugden B. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 Molecular and Cellular Biology. 6: 3838-3846. PMID 3025615  0.368
1985 Reisman D, Yates J, Sugden B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components Molecular and Cellular Biology. 5: 1822-1832. PMID 3018528  0.366
1985 Miller G, Sugden B. An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed Virology. 143: 478-484. PMID 2998023 DOI: 10.1016/0042-6822(85)90387-3  0.347
1985 Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells Nature. 313: 812-815. PMID 2983224 DOI: 10.1038/313812a0  0.437
1985 Sugden B, Marsh K, Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus Molecular and Cellular Biology. 5: 410-413. PMID 2983194  0.361
1984 Sugden B, Yates J, Mark W. Transforming functions associated with Epstein-Barr virus Journal of Investigative Dermatology. 83. PMID 6330229  0.419
1984 Yates J, Warren N, Reisman D, Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells Proceedings of the National Academy of Sciences of the United States of America. 81: 3806-3810. PMID 6328526  0.395
1984 Reisman D, Sugden B. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained Virology. 137: 113-126. PMID 6089410 DOI: 10.1016/0042-6822(84)90014-X  0.39
1982 Mark W, Sugden B. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome Virology. 122: 431-443. PMID 6293180 DOI: 10.1016/0042-6822(82)90242-2  0.337
1982 Sugden B. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro Reviews of Infectious Diseases. 4: 1048-1061. PMID 6293034  0.403
1982 Grunwald DJ, Dale B, Dudley J, Lamph W, Sugden B, Ozanne B, Risser R. Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells Journal of Virology. 43: 92-103. PMID 6287020  0.314
1981 Kintner C, Sugden B. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus. Nature. 294: 458-60. PMID 6273741 DOI: 10.1038/294458A0  0.359
1981 Kintner C, Sugden B. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. Journal of Virology. 38: 305-16. PMID 6264105 DOI: 10.1128/Jvi.38.1.305-316.1981  0.383
1979 Sugden B, Phelps M, Domoradzki J. Epstein-Barr virus DNA is amplified in transformed lymphocytes Journal of Virology. 31: 590-595. PMID 229241  0.316
1977 Sugden B. Comparison of Epstein-Barr viral DNAs in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro Proceedings of the National Academy of Sciences of the United States of America. 74: 4651-4655. PMID 200925  0.387
1977 Sugden B, Mark W. Clonal transformation of adult human leukocytes by Epstein-Barr virus Journal of Virology. 23: 503-508. PMID 197258  0.359
1975 Sugden B, DeTroy B, Roberts RJ, Sambrook J. Agarose slab-gel electrophoresis equipment Analytical Biochemistry. 68: 36-46. PMID 1190452 DOI: 10.1016/0003-2697(75)90676-4  0.365
1975 Sugden B. Viral RNA in cells carrying Epstein Barr virus Iarc (International Agency For Research On Cancer) Scientific Publications. 171-176. PMID 190121  0.325
1974 Klein G, Sugden B, Leibold W, Menezes J. Infection of EBV-genome-negative and-positive human lymphoblastoid: Cell lines with biologically different preparations of EBV Intervirology. 3: 232-244. PMID 4376804 DOI: 10.1159/000149760  0.445
1974 Botchan M, Ozanne B, Sugden B, Sharp PA, Sambrook J. Viral DNA in transformed cells. III. The amounts of different regions of the SV40 genome present in a line of transformed mouse cells Proceedings of the National Academy of Sciences of the United States of America. 71: 4183-4187. PMID 4372611 DOI: 10.1073/Pnas.71.10.4183  0.735
1973 Sharp PA, Sugden B, Sambrook J. Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose-ethidium bromide electrophoresis Biochemistry. 12: 3055-3063. PMID 4354250 DOI: 10.1021/Bi00740A018  0.564
1973 Sambrook J, Sugden B, Keller W, Sharp PA. Transcription of simian virus 40. III. Mapping of 'early' and 'late' species of RNA Proceedings of the National Academy of Sciences of the United States of America. 70: 3711-3715. PMID 4129925 DOI: 10.1073/Pnas.70.12.3711  0.633
1972 Jackson AH, Sugden B. Inhibition by -amanitin of simian virus 40-specific ribonucleic acid synthesis in nuclei of infected monkey cells Journal of Virology. 10: 1086-1089. PMID 4344254 DOI: 10.1128/Jvi.10.5.1086-1089.1972  0.381
1970 Sugden B, Sambrook J. RNA Polymerase from HeLa Cells Cold Spring Harbor Symposia On Quantitative Biology. 35: 663-669. DOI: 10.1101/Sqb.1970.035.01.082  0.47
Show low-probability matches.